Tiago Girao is CFO at Immunovant, Inc. (IMVT). They have made 5 open-market trades across 2 companies since 2014, most recently 2026-07-23.
CIK 0001618670
2 open-market purchases totalling $33K since 2014, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IMVT | 240,798 | $6.4M |
| CYTX | 14,084 | $3K |
| Total | $6.4M |
Shares reported on the most recent Form 4, priced at the 2026-07-24 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMVT | SELL | 2026-07-23 | 2026-07-24 | $38.69 | $263K | -1.8% | +8.2% | — |
| IMVT | SELL | 2026-06-26 | 2026-06-26 | $38.46 | $385K | +6.4% | +3.8% | -11.9% |
| IMVT | SELL | 2026-04-23 | 2026-04-24 | $29.62 | $763K | +0.4% | +18.4% | +38.0% |
| CYTX | BUY | 2015-08-18 | 2015-08-19 | $0.39 | $10K | -23.7% | -1.4% | -1.4% |
| CYTX | BUY | 2014-11-11 | 2014-11-12 | $0.39 | $23K | -23.7% | -1.4% | -1.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.